December 16, 2021 10:31 AM EST
China
Pharma

US black­lists Chi­nese re­search in­sti­tutes over 'brain con­trol' ef­forts as in­vestor frets roil biotech stocks

John Carroll

Editor & Founder

The US gov­ern­ment is black­list­ing a group of re­search in­sti­tutes in Chi­na for us­ing “biotech­nol­o­gy process­es to sup­port Chi­nese mil­i­tary end …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis pays $1B up­front for PTC's Phase 2 Hunt­ing­ton's drug

Merus drug shows ‘un­ex­pect­ed im­prove­ment’ in sec­ond-line head and neck can­cer study

Apogee tar­gets Dupix­ent head-to-head next year as it out­lines broad pipeline plans

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take blue­bird's Skysona gene ther­a­py

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times